1 month 0
Extreme 0.0003
0
3 years 0
Extreme 0.0002
0
5 years 0
Extreme 0.0002
0.01
Manager TitleAgeSince
Chief Executive Officer - 2011-05-22
Director of Finance/CFO - 2011-05-22
Director TitleAgeSince
Director/Board Member - 2011-05-22
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+33.33%-.--% - - 0
+1.59%+7.24%+3.69%+43.24% 41.63B
+0.56%+5.53%-34.08%-25.95% 22.84B
+0.57%+9.30%-3.96% - 18.87B
+0.11%+5.18%+0.18%+43.03% 6.14B
-0.70%+9.91%+1.97%+85.45% 4.06B
+1.25%+3.95%+6.31%+8.85% 1.27B
0.00%0.00%-1.23% - 950M
-2.45%+0.56%-19.70%+72.99% 865M
-0.68%+1.87%+34.12%+65.56% 815M
Average +3.36%+3.13%-1.41%+41.88% 9.74B
Weighted average by Cap. +0.89%+5.04%-6.90%+25.07%
Logo ITONIS IN
Itonis Inc. operates as a holding company. The Company’s Pharmaceuticals division to produce and market over the counter and prescription homeopathic preparations to treat both common ailments and chronic diseases. The Company has launched the retails sale of the Emesyl nausea relief product. The Company has identified the market for its Emesyl product line as the general public who suffers from nausea. Emesyl has been available for purchase at https://www.amazon.com/dp/B00U20H3KI and www.Emesyl.com. Its subsidiaries include Itonis Holdings, Inc., Itonis Pharmaceuticals, and Paramount Discoveries, Inc.
Employees
-
  1. Stock Market
  2. Stocks
  3. ITNS Stock